Published 14 November 2008, doi:10.1136/bmj.a2199
Cite this as: BMJ 2008;337:a2199

Practice

Uncertainties Page

What is the optimal management of partial epilepsy uncontrolled by a first choice anticonvulsant?

David W Chadwick, emeritus professor of neurology1, Gus A Baker, professor of neuropsychology1, Ann Jacoby, research professor, Division of Public Health1, Anthony G Marson, reader in neurology1, Phil E Smith, consultant and honorary professor2

1 University of Liverpool, Walton Centre, Liverpool L9 7LJ, 2 University Hospital of Wales, Cardiff CF14 4XW

Correspondence to: D W Chadwick d.w.chadwick@liverpool.ac.uk

The first 150 words of the full text of this article appear below.

Up to 70% of people who are treated with a single anticonvulsant will enter remission within a short time of being diagnosed with epilepsy.1 Optimal first choice treatments have been identified in some comparative randomised controlled trials and guidelines from the National Institute for Health and Clinical Excellence.2 3 Lamotrigine or carbamazepine are usually the preferred initial treatment of seizures with localised onset in the brain, whereas valproate is preferred for generalised epilepsy syndromes.4 5

However, despite optimal doses of a first line anticonvulsant, many patients with localised onset seizures (10-15/100 000 each year worldwide) do not enter remission and continue to have seizures of varying severity and frequency, which are associated with considerable psychosocial distress.6 7 The evidence base to support management of these patients is minimal,2 and it is uncertain which of the following available options is optimal:


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?
Access jobs at BMJ Careers
Whats new online at Student BMJ